Reversible Left Ventricular Systolic Dysfunction Secondary to Pazopanib.
作者信息
Gajjar Kushani, Balakumaran Kathir, Kim Agnes S
机构信息
Internal Medicine, University of Connecticut Health Center, Farmington, USA.
Cardiology, University of Connecticut Health Center, Farmington, USA.
出版信息
Cureus. 2018 Oct 29;10(10):e3517. doi: 10.7759/cureus.3517.
Abstract
Pazopanib is a tyrosine kinase inhibitor used for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma. We describe a case report of a patient with spindle cell sarcoma who developed severe left ventricular systolic dysfunction after starting pazopanib therapy with subsequent recovery of left ventricular ejection fraction upon stopping therapy.
摘要
Zotero 插件